SG170044A1 - Ocular allergy treatments - Google Patents
Ocular allergy treatmentsInfo
- Publication number
- SG170044A1 SG170044A1 SG201101394-3A SG2011013943A SG170044A1 SG 170044 A1 SG170044 A1 SG 170044A1 SG 2011013943 A SG2011013943 A SG 2011013943A SG 170044 A1 SG170044 A1 SG 170044A1
- Authority
- SG
- Singapore
- Prior art keywords
- ocular allergy
- allergy treatments
- treatments
- ocular
- alcaftadine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78818506P | 2006-03-31 | 2006-03-31 | |
| US68801607A | 2007-03-19 | 2007-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG170044A1 true SG170044A1 (en) | 2011-04-29 |
Family
ID=38468943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201101394-3A SG170044A1 (en) | 2006-03-31 | 2007-03-26 | Ocular allergy treatments |
Country Status (30)
| Country | Link |
|---|---|
| US (7) | US8664215B2 (da) |
| EP (2) | EP2004196B1 (da) |
| JP (3) | JP5292277B2 (da) |
| KR (1) | KR101321731B1 (da) |
| CN (1) | CN102895234A (da) |
| AR (1) | AR060278A1 (da) |
| AU (1) | AU2007234957B2 (da) |
| BR (1) | BRPI0710085B8 (da) |
| CA (1) | CA2648115C (da) |
| CL (1) | CL2007000916A1 (da) |
| CR (1) | CR10414A (da) |
| DK (2) | DK3150209T3 (da) |
| EA (1) | EA016221B1 (da) |
| EC (1) | ECSP088786A (da) |
| ES (2) | ES2752823T3 (da) |
| HK (1) | HK1131331A1 (da) |
| IL (1) | IL194473A (da) |
| JO (1) | JO3358B1 (da) |
| MX (1) | MX2008012657A (da) |
| MY (1) | MY153669A (da) |
| NI (1) | NI200800261A (da) |
| NO (1) | NO341147B1 (da) |
| NZ (1) | NZ571690A (da) |
| PE (1) | PE20080053A1 (da) |
| PL (2) | PL3150209T3 (da) |
| SG (1) | SG170044A1 (da) |
| TW (2) | TWI578990B (da) |
| UY (1) | UY30254A1 (da) |
| WO (1) | WO2007117971A2 (da) |
| ZA (1) | ZA200809327B (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2004196B1 (en) | 2006-03-31 | 2016-06-29 | Vistakon Pharmaceuticals, LLC | Ocular allergy treatments |
| AU2007243334A1 (en) | 2006-04-26 | 2007-11-08 | Aciex Therapeutics, Inc. | Compositions for the treatment and prevention of eyelid swelling |
| WO2009061431A2 (en) * | 2007-11-08 | 2009-05-14 | Aciex Therapeutics, Inc. | Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor |
| PT2408453T (pt) | 2009-03-17 | 2022-04-05 | Nicox Ophthalmics Inc | Formulações oftálmicas de cetirizina e métodos de utilização |
| US8569273B2 (en) | 2009-03-17 | 2013-10-29 | Aciex Therapeutics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| EP2664329A1 (de) * | 2012-05-15 | 2013-11-20 | F. Holzer GmbH | Ophthalmologisches Vehikelsystem |
| US9409913B2 (en) * | 2012-11-21 | 2016-08-09 | Enaltec Labs Private Limited | Polymorphic forms of alcaftadine |
| WO2014087208A2 (en) * | 2012-12-06 | 2014-06-12 | Enaltec Labs Pvt. Ltd. | A process of preparing alcaftadine |
| US11242367B2 (en) | 2016-08-12 | 2022-02-08 | Silk Technologies, Ltd. | Silk-derived protein for treating inflammation |
| WO2019022225A1 (ja) * | 2017-07-28 | 2019-01-31 | 参天製薬株式会社 | アルカフタジン又はその塩を含有する水性医薬組成物 |
| JPWO2019026992A1 (ja) * | 2017-08-03 | 2020-06-18 | 参天製薬株式会社 | クロルヘキシジンを含有する医薬組成物 |
| EP3740191B1 (en) | 2018-01-18 | 2021-04-28 | Faes Farma, S.A. | Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent |
| KR20230024928A (ko) | 2020-06-15 | 2023-02-21 | 알켐 라보라토리즈 리미티드 | 알카프타딘과 코르티코스테로이드의 병용 |
| CA3209420A1 (en) | 2021-02-24 | 2022-09-01 | Peter Jarrett | Intracanalicular depot inserter device |
| US20240173331A1 (en) | 2021-04-01 | 2024-05-30 | Alkem Laboratories Limited | Nasal compositions comprising alcaftadine |
| TW202408472A (zh) * | 2022-07-06 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
| TW202408468A (zh) * | 2022-07-06 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
| WO2024204749A1 (ja) * | 2023-03-31 | 2024-10-03 | ロート製薬株式会社 | 眼科組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4148903A (en) | 1977-07-28 | 1979-04-10 | Merck & Co., Inc. | Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines |
| DE3134672A1 (de) | 1981-09-02 | 1983-03-17 | Boehringer Ingelheim KG, 6507 Ingelheim | Heterocyclische verbindungen, ihre herstellung und verwendung |
| GB8900380D0 (en) | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
| US5393753A (en) | 1990-10-10 | 1995-02-28 | Schering Corporation | Substituted imidazobenzazepines |
| IT1248014B (it) * | 1991-06-07 | 1995-01-05 | Inverni Della Beffa Spa | Preparazioni oftalmiche a rilascio protratto |
| IL101850A (en) * | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them |
| US5641805A (en) | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
| US20060100408A1 (en) * | 2002-03-11 | 2006-05-11 | Powell P M | Method for forming contact lenses comprising therapeutic agents |
| US20070077302A1 (en) | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
| US20070077303A1 (en) | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for providing oxidatively stable ophthalmic compositions |
| EP2010143B1 (en) | 2006-03-17 | 2015-08-12 | Johnson & Johnson Vision Care, Inc. | Stabilized ophthalmic compositions comprising oxidatively unstable components |
| EP2004196B1 (en) | 2006-03-31 | 2016-06-29 | Vistakon Pharmaceuticals, LLC | Ocular allergy treatments |
-
2007
- 2007-03-26 EP EP07759365.5A patent/EP2004196B1/en active Active
- 2007-03-26 CA CA2648115A patent/CA2648115C/en active Active
- 2007-03-26 WO PCT/US2007/064911 patent/WO2007117971A2/en active Application Filing
- 2007-03-26 EP EP16176695.1A patent/EP3150209B1/en active Active
- 2007-03-26 JP JP2009503195A patent/JP5292277B2/ja active Active
- 2007-03-26 NZ NZ571690A patent/NZ571690A/en unknown
- 2007-03-26 BR BRPI0710085A patent/BRPI0710085B8/pt active IP Right Grant
- 2007-03-26 DK DK16176695T patent/DK3150209T3/da active
- 2007-03-26 PL PL16176695T patent/PL3150209T3/pl unknown
- 2007-03-26 PL PL07759365T patent/PL2004196T3/pl unknown
- 2007-03-26 KR KR1020087026545A patent/KR101321731B1/ko active IP Right Review Request
- 2007-03-26 MX MX2008012657A patent/MX2008012657A/es active IP Right Grant
- 2007-03-26 SG SG201101394-3A patent/SG170044A1/en unknown
- 2007-03-26 DK DK07759365.5T patent/DK2004196T3/da active
- 2007-03-26 CN CN2012103679852A patent/CN102895234A/zh active Pending
- 2007-03-26 US US11/690,954 patent/US8664215B2/en active Active
- 2007-03-26 EA EA200870396A patent/EA016221B1/ru unknown
- 2007-03-26 AU AU2007234957A patent/AU2007234957B2/en active Active
- 2007-03-26 ES ES16176695T patent/ES2752823T3/es active Active
- 2007-03-26 ES ES07759365.5T patent/ES2594655T3/es active Active
- 2007-03-30 TW TW103115261A patent/TWI578990B/zh active
- 2007-03-30 TW TW096111374A patent/TWI450721B/zh active
- 2007-04-01 JO JOP/2007/0103A patent/JO3358B1/ar active
- 2007-04-02 PE PE2007000398A patent/PE20080053A1/es active IP Right Grant
- 2007-04-02 CL CL2007000916A patent/CL2007000916A1/es unknown
- 2007-04-02 UY UY30254A patent/UY30254A1/es not_active Application Discontinuation
- 2007-04-03 AR ARP070101408A patent/AR060278A1/es not_active Application Discontinuation
-
2008
- 2008-09-30 MY MYPI20083927A patent/MY153669A/en unknown
- 2008-09-30 NI NI200800261A patent/NI200800261A/es unknown
- 2008-10-01 EC EC2008008786A patent/ECSP088786A/es unknown
- 2008-10-02 IL IL194473A patent/IL194473A/en active IP Right Grant
- 2008-10-29 NO NO20084593A patent/NO341147B1/no unknown
- 2008-10-30 CR CR10414A patent/CR10414A/es unknown
- 2008-10-30 ZA ZA2008/09327A patent/ZA200809327B/en unknown
-
2009
- 2009-10-15 HK HK09109552.2A patent/HK1131331A1/en unknown
-
2011
- 2011-02-04 US US13/020,961 patent/US20120094978A1/en not_active Abandoned
-
2013
- 2013-03-25 JP JP2013061939A patent/JP2013144703A/ja not_active Withdrawn
- 2013-10-08 US US14/049,078 patent/US20140107102A1/en not_active Abandoned
-
2015
- 2015-02-20 JP JP2015031395A patent/JP6039716B2/ja active Active
-
2016
- 2016-09-16 US US15/267,645 patent/US10617695B2/en active Active
-
2020
- 2020-03-11 US US16/815,967 patent/US20210030762A1/en not_active Abandoned
-
2022
- 2022-07-20 US US17/813,728 patent/US20230181594A1/en not_active Abandoned
-
2023
- 2023-02-28 US US18/175,787 patent/US20240058355A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG170044A1 (en) | Ocular allergy treatments | |
| WO2008029276A3 (en) | Compositions and methods for the treatment of ophthalmic disease | |
| LT1854477T (lt) | Peptidai, slopinantys plazmos kalikreiną, skirti naudoti oftalmologinių sutrikimų gydymui | |
| ZA200810113B (en) | Method for the treatment and prevention of ocular disorders | |
| ZA201201391B (en) | Methods, compositions, and kits for the treatment of medical conditions | |
| WO2007106537A3 (en) | Aminoquinolones as gsk-3 inhibitors | |
| WO2006097337A3 (en) | 11β-HYDROXYSTEROID DEHYDROGENASES | |
| WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
| EP2192901A4 (en) | CHEMICAL AGENTS, COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF ORTHOPOXVIRUS INFECTIONS AND RELATED DISEASES | |
| WO2006074265A3 (en) | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders | |
| WO2009035634A3 (en) | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors | |
| WO2007140317A3 (en) | Use of inhibitors of cytosolic ph0sph0lipase a2 in the treatment of thrombosis | |
| HK1102626A1 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
| WO2007041388A3 (en) | Prevention and treatment of hearing disorders | |
| WO2007147868A3 (en) | Prevention of muscle atrophy | |
| AR111697A2 (es) | Composición oftálmica para el tratamiento de las alergias oculares | |
| WO2007108004A3 (en) | S-alkylisothiouronium derivatives for the treatment of inflammatory diseases | |
| WO2008063853A3 (en) | Cancer treatment method | |
| WO2007123686A3 (en) | Dpp inhibitors and uses thereof | |
| WO2007117272A3 (en) | Methods for treatment of hemorrhagic shock and related disorders | |
| WO2007084964A3 (en) | Pharmaceutical composition comprising a protein pump inhibitor and protein component | |
| SI1854477T1 (sl) | Peptidi, ki inhibirajo plazma kalikrein za uporabo pri zdravljenju očesnih motenj | |
| MX2009008734A (es) | Gamma lactamas para el tratamiento de glaucoma o hipertension intraocular. | |
| AU2014246580B9 (en) | Ocular allergy treatments | |
| WO2008021788A3 (en) | Polyamine compounds |